Ranbaxy Laboratories, India's major drug manufacturer has reported a jump of 30.26 times in its consolidated net profit for the quarter ended June 2009.

During the reporting quarter, the company has clocked a consolidated net profit of Rs 6,931 million.

Ranbaxy Laboratories stated in a communiqué that it has recorded a much higher profit compared to a net profit of Rs 229 million in the year ago period.

Company's consolidated net sales during the quarter under review have witnessed a dip of 2% to Rs 17,953 million when compared with the figures of previous year period.

Shares of the company gained Rs 5.25, or 1.91%, to settle at Rs 279.65 on Bombay Stock Exchange (BSE). The total volume of shares traded was 628,065 at the BSE (Friday).